CLSK vs CPSS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CLSK

55.6
AI Score
VS
CLSK Wins

CPSS

49.4
AI Score

Investment Advisor Scores

CLSK

56score
Recommendation
HOLD

CPSS

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLSK CPSS Winner
Revenue 289.69M 233.72M CLSK
Net Income -83.60M 11.77M CPSS
Net Margin -28.9% 5.0% CPSS
ROE -6.0% 3.7% CPSS
ROA -5.7% 0.3% CPSS
Total Assets 1.48B 4.42B CPSS
Cash 126.14M 7.50M CLSK

Relative Price Performance (Last 90 Days)

CLSK 1M: -43.6% · 3M: -43.9% CPSS 1M: -1.0% · 3M: -2.1%

Current Technical Phase

CLSK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.3%), weak momentum, RSI 25

RSI (14): 25.5 · Price: $8.15

CPSS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.2 · Price: $9.25

Fundamentals Snapshot

Metric CLSK CPSS
Market Cap — —
Forward P/E -4.5 3.9
Trailing P/E — 9.9
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 0.5% 1.0%
Operating Margin -1.7% 0.2%
EPS -3.78 0.91
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLSK is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.